The Patent Finder

NV reMYND

Also on record
Records under this name other than patents NV reMYND holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 3 of 3 · Back to NV reMYND

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,722,681N-sulfonyl thiazolylpiperazine derivatives and related N-sulfonyl heterocyclic derivatives for the treatment of neuro degenerative diseases
Lapsed on the fee record
Ended May 13, 2026 · USPTO record
Lapsed on the fee recordEnded May 13, 2026USPTO record
US 8,541,406Thiadiazole derivatives for the treatment of neurodegenerative diseases
Lapsed on the fee record
Ended Sep 24, 2025 · USPTO record
Lapsed on the fee recordEnded Sep 24, 2025USPTO record
US 7,960,556Thiadiazole derivatives for the treatment of neuro-degenerative diseases
Lapsed on the fee record
Ended Jun 14, 2019 · USPTO record
Lapsed on the fee recordEnded Jun 14, 2019USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited